Neurox

Composition: Ethylmethylhydroxypyridine succinate

Form: Solution for intravenous and intramuscular injection

Indications: Acute cerebrovascular accident, traumatic brain injury, discirculatory encephalopathy, neurocirculatory dystonia, anxiety and neurosis-like states, cognitive impairments in the elderly, myocardial infarction, primary open-angle glaucoma, withdrawal syndrome, neuroleptic intoxication.

Contraindications: Hypersensitivity, acute renal and hepatic failure, pregnancy and lactation, childhood.

Dosage: IV (drip or jet in 0.9% NaCl) or IM: - Stroke and TBI: 200–500 mg 2–4 times/day for 10–14 days, then IM 200–250 mg 2–3 times/day for 2 weeks; - Encephalopathy: IV 200–500 mg 1–2 times/day for 14 days, then IM 200–250 mg for 10–14 days; - Anxiety and dystonia: IM 50–400 mg/day for 14 days; - Myocardial infarction: 6–9 mg/kg/day, max 1200 mg/day.

Side effects: Dry mouth, metallic taste, throat heat and scratchiness, chest discomfort, shortness of breath (during rapid infusion); possible allergy, insomnia or drowsiness, bloating, nausea.

Interactions: Enhances the effects of benzodiazepines, antiepileptic and antiparkinsonian drugs, nitrates. Reduces alcohol toxicity.

Warnings: May cause drowsiness — avoid driving. Discontinue immediately in case of hypotension or allergy. Contraindicated during pregnancy and lactation.

Age restrictions: 18+

Pregnancy: Contraindicated during pregnancy and breastfeeding.

Country of origin: Russia

Manufacturer: Sotex

Storage conditions: Store at temperatures not exceeding 25 °C, in a dark place. Do not freeze. Keep out of reach of children.